Elon Musk’s Neuralink Gains Approval for Human Trials of Brain Interfaces
Elon Musk’s company Neuralink, still in its startup phase, has been granted permission by US regulators to conduct human trials of its implanted brain sensors, marking a significant milestone in the company’s journey. After multiple previous attempts, Neuralink has finally obtained the go-ahead for human clinical trials.
The information came to light, as reported by CNBC, from statements by Neuralink representatives, although the company has not yet begun seeking volunteers to participate in the clinical trials of the so-called “brain interface.” Just yesterday, Neuralink received approval from the US Food and Drug Administration (FDA) for human clinical trials.
The implants, which have been tested on pigs and monkeys, are placed in the skull in close proximity to the brain’s cortex. Theoretically, these should enable paralyzed patients to control a computer cursor literally by “the power of thought,” paving the way for the creation of specialized bionic prostheses and allowing individuals who have lost control of their speech apparatus and motor functions to regain the ability to communicate with their surroundings. Besides drilling a hole in the skull, installing a Neuralink sensor involves implanting thin electrodes into parts of the patient’s brain cortex.
Elon Musk’s promising startup has so far had a somewhat complex history of interaction with regulatory bodies. Complaints from activists about the supposed inhumane treatment of experimental animals were supplemented by violations in the transportation rules of biological waste. In March, the FDA rejected Neuralink’s application for human clinical trials, indicating the need for the company to address dozens of issues.
At the end of last year, Elon Musk even expressed his willingness to have a Neuralink implant himself someday, underscoring the potential and safety of this development. Despite the hurdles and criticisms, this approval represents a significant step forward in Neuralink’s mission to bridge the gap between the human brain and artificial intelligence.
Author Profile
- I'm Vasyl Kolomiiets, a seasoned tech journalist regularly contributing to global publications. Having a profound background in information technologies, I seamlessly blended my technical expertise with my passion for writing, venturing into technology journalism. I've covered a wide range of topics including cutting-edge developments and their impacts on society, contributing to leading tech platforms.
Latest entries
Troubleshooting15/11/2023Intel Fixes Critical Vulnerability Affecting All Processors – CVE-2023-23583
Business15/11/2023Google Pays $8 Billion to Samsung for Default ‘Play Market’ and Search in Galaxy Devices
Technology04/11/2023North Korea Upgrades Mobile Networks with Huawei Equipment Imports
Technology03/11/2023Chinese Scientists Invent Passive Saltwater Cooler, Boosts CPU Speed by a Third
